- Home
- EWTX vs CLBT Comparison
EWTX vs CLBT Comparison
Compare EWTX & CLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWTX | CLBT |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | EWTX | CLBT |
|---|---|---|
| Price | $30.05 | $13.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $34.71 | $22.50 |
| AVG Volume (30 Days) | 691.3K | ★ 2.3M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.45 |
| Revenue Next Year | N/A | $17.47 |
| P/E Ratio | ★ N/A | $45.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.60 | $11.76 |
| 52 Week High | $31.82 | $20.86 |
Technical Indicators
Market Signals| Indicator | EWTX | CLBT |
|---|---|---|
| Relative Strength Index (RSI) | 54.85 | 43.41 |
| Support Level | $13.56 | $13.11 |
| Resistance Level | $30.77 | $15.13 |
| Average True Range (ATR) | 1.49 | 0.79 |
| MACD | -0.16 | 0.04 |
| Stochastic Oscillator | 52.72 | 53.86 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About CLBT Cellebrite DI Ltd.
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.